TUCSON, Ariz.--(BUSINESS WIRE)--Ventana Medical Systems, Inc. (NASDAQ: VMSI), the global leader in tissue-based cancer diagnostics, today issued the following statement regarding Roche’s decision to extend its unsolicited tender offer to acquire all outstanding shares of Ventana for $75.00 in cash per common share:
